Successful Osimertinib Rechallenge after Severe Osimertinib-Induced Hepatotoxicity

J Thorac Oncol. 2017 May;12(5):e61-e63. doi: 10.1016/j.jtho.2017.01.026. Epub 2017 Mar 11.

Authors

Hironori Yoshida¹, Young Hak Kim²

Affiliations

¹ Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
² Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Electronic address: ekim@kuhp.kyoto-u.ac.jp.

PMID: 28291724
DOI: 10.1016/j.jtho.2017.01.026

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Acrylamides
Aged
Aniline Compounds
Antineoplastic Agents / administration & dosage
Antineoplastic Agents / adverse effects
Chemical and Drug Induced Liver Injury / etiology*
Chemical and Drug Induced Liver Injury / pathology
Female
Humans
Piperazines / administration & dosage
Piperazines / adverse effects*

Substances

Acrylamides
Aniline Compounds
Antineoplastic Agents
Piperazines
osimertinib